<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37762010</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>18</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>05</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Anti-Inflammatory Effects of Miyako <i>Bidens pilosa</i> in a Mouse Model of Amyotrophic Lateral Sclerosis and Lipopolysaccharide-Stimulated BV-2 Microglia.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">13698</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms241813698</ELocationID><Abstract><AbstractText>Neuroinflammation is a fundamental feature in the pathogenesis of amyotrophic lateral sclerosis (ALS) and arises from the activation of astrocytes and microglial cells. Previously, we reported that Miyako <i>Bidens pilosa</i> extract (MBP) inhibited microglial activation and prolonged the life span in a human ALS-linked mutant <i>superoxide dismutase-1</i> (<i>SOD1</i><sup>G93A</sup>) transgenic mouse model of ALS (G93A mice). Herein, we evaluated the effect of MBP on microglial activation in the spinal cord of G93A mice and lipopolysaccharide-stimulated BV-2 microglial cells. The administration of MBP inhibited the upregulation of the M1-microglia/macrophage marker (interferon-&#x3b3; receptor (IFN-&#x3b3;R)) and pro-inflammatory cytokines (tumor necrosis factor (TNF)-&#x3b1;, interleukin (IL)-1&#x3b2;, and IL-6) in G93A mice. However, MBP did not affect the increase in the M2-microglia/macrophage marker (IL-13R) and anti-inflammatory cytokines (transforming growth factor (TGF)-&#x3b2; and IL-10) in G93A mice. BV-2 cell exposure to MBP resulted in a decrease in 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium (MTT) reduction activity and bromodeoxyuridine incorporation, without an increase in the number of ethidium homodimer-1-stained dead cells. Moreover, MBP suppressed the production of lipopolysaccharide-induced pro-inflammatory cytokines (TNF-&#x3b1;, IL-1&#x3b2;, and IL-6) in BV-2 cells. These results suggest that the selective suppression of M1-related pro-inflammatory cytokines is involved in the therapeutic potential of MBP in ALS model mice.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tsuruta</LastName><ForeName>Komugi</ForeName><Initials>K</Initials><Identifier Source="ORCID">0009-0001-9920-7874</Identifier><AffiliationInfo><Affiliation>Laboratory of Pharmacology, School of Pharmacy, Nihon University, 7-7-1 Narashinodai, Funabashi 274-8555, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shidara</LastName><ForeName>Takato</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Laboratory of Pharmacology, School of Pharmacy, Nihon University, 7-7-1 Narashinodai, Funabashi 274-8555, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miyagishi</LastName><ForeName>Hiroko</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-3909-867X</Identifier><AffiliationInfo><Affiliation>Laboratory of Pharmacology, School of Pharmacy, Nihon University, 7-7-1 Narashinodai, Funabashi 274-8555, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nango</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-8271-9937</Identifier><AffiliationInfo><Affiliation>Laboratory of Pharmacology, School of Pharmacy, Nihon University, 7-7-1 Narashinodai, Funabashi 274-8555, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakatani</LastName><ForeName>Yoshihiko</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pharmacotherapeutics, School of Pharmacy, International University of Health and Welfare, 2600-1 Kitakanemaru, Ohtawara 324-8501, Tochigi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suzuki</LastName><ForeName>Naoto</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-8272-8481</Identifier><AffiliationInfo><Affiliation>Laboratory of Pharmaceutics, School of Pharmacy, Nihon University, 7-7-1 Narashinodai, Funabashi 274-8555, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amano</LastName><ForeName>Taku</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Tochigi Prefectural Okamotodai Hospital, 2162 Shimookamotomachi, Utsunomiya 329-1104, Tochigi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suzuki</LastName><ForeName>Toyofumi</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-1374-4899</Identifier><AffiliationInfo><Affiliation>Laboratory of Pharmaceutics, School of Pharmacy, Nihon University, 7-7-1 Narashinodai, Funabashi 274-8555, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kosuge</LastName><ForeName>Yasuhiro</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-7513-5132</Identifier><AffiliationInfo><Affiliation>Laboratory of Pharmacology, School of Pharmacy, Nihon University, 7-7-1 Narashinodai, Funabashi 274-8555, Chiba, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>22K06654 (Y.K.) and 21K06620 (H.M. and Y.K.)</GrantID><Agency>JSPS KAKENHI</Agency><Country/></Grant><Grant><GrantID>2211</GrantID><Agency>a Nihon University Research Grant for 2022-2023</Agency><Country/></Grant><Grant><GrantID>2019</GrantID><Agency>Shorei Foundation for Science and Technology</Agency><Country/></Grant><Grant><GrantID>2020</GrantID><Agency>The Research Foundation for Pharmaceutical Sciences</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008070">Lipopolysaccharides</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C531617">Amyotrophic lateral sclerosis 1</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D031176" MajorTopicYN="Y">Bidens</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008070" MajorTopicYN="N">Lipopolysaccharides</DescriptorName><QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bidens pilosa</Keyword><Keyword MajorTopicYN="N">M1-microglia/macrophages</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">pro-inflammatory cytokines</Keyword><Keyword MajorTopicYN="N">spinal cord</Keyword></KeywordList><CoiStatement>Yasuhiro Kosuge had grants from Refine Holdings Co., Ltd., and the other authors declare no competing financial interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37762010</ArticleId><ArticleId IdType="pmc">PMC10530530</ArticleId><ArticleId IdType="doi">10.3390/ijms241813698</ArticleId><ArticleId IdType="pii">ijms241813698</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O&#x2019;Regan J.P., Deng H.X., et al. Mutations in Cu/Zn Superoxide Dismutase Gene Are Associated with Familial Amyotrophic Lateral Sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.-X., et al. Motor Neuron Degeneration in Mice That Express a Human Cu, Zn Superoxide Dismutase Mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Miana-Mena F.J., Gonz&#xe1;lez-Mingot C., Larrod&#xe9; P., Mu&#xf1;oz M.J., Oliv&#xe1;n S., Fuentes-Broto L., Mart&#xed;nez-Ballar&#xed;n E., Reiter R.J., Osta R., Garc&#xed;a J.J. Monitoring Systemic Oxidative Stress in an Animal Model of Amyotrophic Lateral Sclerosis. J. Neurol. 2011;258:762&#x2013;769. doi: 10.1007/s00415-010-5825-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-010-5825-8</ArticleId><ArticleId IdType="pubmed">21108037</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalmar B., Novoselov S., Gray A., Cheetham M.E., Margulis B., Greensmith L. Late Stage Treatment with Arimoclomol Delays Disease Progression and Prevents Protein Aggregation in the SOD1G93A Mouse Model of ALS. J. Neurochem. 2008;107:339&#x2013;350. doi: 10.1111/j.1471-4159.2008.05595.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2008.05595.x</ArticleId><ArticleId IdType="pubmed">18673445</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai M., Choi S.-M., Song B.K., Son I., Kim S., Yang E.J. Scolopendra Subspinipes Mutilans Attenuates Neuroinflammation in Symptomatic hSOD1G93A mice. J. Neuroinflamm. 2013;10:131.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4231348</ArticleId><ArticleId IdType="pubmed">24168240</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J., Hyeon S.J., Im H., Ryu H., Kim Y., Ryu H. Astrocytes and Microglia as Non-Cell Autonomous Players in the Pathogenesis of ALS. Exp. Neurobiol. 2016;25:233&#x2013;240. doi: 10.5607/en.2016.25.5.233.</Citation><ArticleIdList><ArticleId IdType="doi">10.5607/en.2016.25.5.233</ArticleId><ArticleId IdType="pmc">PMC5081469</ArticleId><ArticleId IdType="pubmed">27790057</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S., Yamanaka K., Lobsiger C.S., Copeland N.G., Jenkins N.A., Kassiotis G., Kollias G., Cleveland D.W. Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia. Science. 2006;312:1389&#x2013;1392. doi: 10.1126/science.1123511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1123511</ArticleId><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K., Chun S.J., Boillee S., Fujimori-Tonou N., Yamashita H., Gutmann D.H., Takahashi R., Misawa H., Cleveland D.W. Astrocytes as Determinants of Disease Progression in Inherited Amyotrophic Lateral Sclerosis. Nat. Neurosci. 2008;11:251&#x2013;253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3137510</ArticleId><ArticleId IdType="pubmed">18246065</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooten K.G., Beers D.R., Zhao W., Appel S.H. Protective and Toxic Neuroinflammation in Amyotrophic Lateral Sclerosis. Neurotherapeutics. 2015;12:364. doi: 10.1007/s13311-014-0329-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-014-0329-3</ArticleId><ArticleId IdType="pmc">PMC4404435</ArticleId><ArticleId IdType="pubmed">25567201</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M.R., Cagnin A., Turkheimer F.E., Miller C.C.J., Shaw C.E., Brooks D.J., Leigh P.N., Banati R.B. Evidence of Widespread Cerebral Microglial Activation in Amyotrophic Lateral Sclerosis: An [11C](R)-PK11195 Positron Emission Tomography Study. Neurobiol. Dis. 2004;15:601&#x2013;609. doi: 10.1016/j.nbd.2003.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2003.12.012</ArticleId><ArticleId IdType="pubmed">15056468</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P., Tauber C., Vercoullie J., Arlicot N., Prunier C., Praline J., Nicolas G., Venel Y., Hommet C., Baulieu J.L., et al. Molecular Imaging of Microglial Activation in Amyotrophic Lateral Sclerosis. PLoS ONE. 2012;7:e52941. doi: 10.1371/journal.pone.0052941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052941</ArticleId><ArticleId IdType="pmc">PMC3534121</ArticleId><ArticleId IdType="pubmed">23300829</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkel J.S., Engelhardt J.I., Sikl&#xf3;s L., Simpson E.P., Kim S.H., Pan T., Goodman J.C., Siddique T., Beers D.R., Appel S.H. Presence of Dendritic Cells, MCP-1, and Activated Microglia/Macrophages in Amyotrophic Lateral Sclerosis Spinal Cord Tissue. Ann. Neurol. 2004;55:221&#x2013;235. doi: 10.1002/ana.10805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.10805</ArticleId><ArticleId IdType="pubmed">14755726</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W., Beers D.R., Henkel J.S., Zhang W., Urushitani M., Julien J.P., Appel S.H. Extracellular Mutant SOD1 Induces Microglial-Mediated Motoneuron Injury. Glia. 2010;58:231&#x2013;243. doi: 10.1002/glia.20919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.20919</ArticleId><ArticleId IdType="pmc">PMC2784168</ArticleId><ArticleId IdType="pubmed">19672969</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X., Zhang J., Li S., Al-Nusaif M., Zhou Q., Chen S., Le W. Bone Marrow Stromal Cell Antigen 2: Is a Potential Neuroinflammation Biomarker of SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis in Pre-Symptomatic Stage. Front. Neurosci. 2022;15:788730. doi: 10.3389/fnins.2021.788730.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2021.788730</ArticleId><ArticleId IdType="pmc">PMC8858987</ArticleId><ArticleId IdType="pubmed">35197819</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu S., Stavrovskaya I.G., Drozda M., Kim B.Y.S., Ona V., Li M., Sarang S., Liu A.S., Hartley D.M., Wu D.C., et al. Minocycline Inhibits Cytochrome c Release and Delays Progression of Amyotrophic Lateral Sclerosis in Mice. Nature. 2002;417:74&#x2013;78. doi: 10.1038/417074a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/417074a</ArticleId><ArticleId IdType="pubmed">11986668</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K., Imagama S., Ohgomori T., Hirano K., Uchimura K., Sakamoto K., Hirakawa A., Takeuchi H., Suzumura A., Ishiguro N., et al. Minocycline Selectively Inhibits M1 Polarization of Microglia. Cell Death Dis. 2013;4:e525. doi: 10.1038/cddis.2013.54.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2013.54</ArticleId><ArticleId IdType="pmc">PMC3613832</ArticleId><ArticleId IdType="pubmed">23470532</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang H.Y., Zhang J.J., Fu Z.F., Liu Y.F., Li S., Chen S., Le W.D. Therapeutic Effects of Hirsutella Sinensis on the Disease Onset and Progression of Amyotrophic Lateral Sclerosis in SOD1G93A Transgenic Mouse Model. CNS Neurosci. Ther. 2020;26:90&#x2013;100. doi: 10.1111/cns.13182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.13182</ArticleId><ArticleId IdType="pmc">PMC6930832</ArticleId><ArticleId IdType="pubmed">31318169</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers D.R., Henkel J.S., Xiao Q., Zhao W., Wang J., Yen A.A., Siklos L., McKercher S.R., Appel S.H. Wild-Type Microglia Extend Survival in PU.1 Knockout Mice with Familial Amyotrophic Lateral Sclerosis. Proc. Natl. Acad. Sci. USA. 2006;103:16021&#x2013;16026. doi: 10.1073/pnas.0607423103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0607423103</ArticleId><ArticleId IdType="pmc">PMC1613228</ArticleId><ArticleId IdType="pubmed">17043238</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y., Le W. Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases. Mol. Neurobiol. 2016;53:1181&#x2013;1194. doi: 10.1007/s12035-014-9070-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-014-9070-5</ArticleId><ArticleId IdType="pubmed">25598354</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo S., Wang H., Yin Y. Microglia Polarization From M1 to M2 in Neurodegenerative Diseases. Front. Aging Neurosci. 2022;14:75. doi: 10.3389/fnagi.2022.815347.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.815347</ArticleId><ArticleId IdType="pmc">PMC8888930</ArticleId><ArticleId IdType="pubmed">35250543</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee W.C., Peng C.C., Chang C.H., Huang S.H., Chyau C.C. Extraction of Antioxidant Components from Bidens pilosa Flowers and Their Uptake by Human Intestinal Caco-2 Cells. Molecules. 2013;18:1582&#x2013;1601. doi: 10.3390/molecules18021582.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules18021582</ArticleId><ArticleId IdType="pmc">PMC6269719</ArticleId><ArticleId IdType="pubmed">23353127</ArticleId></ArticleIdList></Reference><Reference><Citation>Horiuchi M., Seyama Y. Antiinflammatory and Antiallergic Activity of Bidens pilosa L. Var. Radiata SCHERFF. J. Health Sci. 2006;52:711&#x2013;717. doi: 10.1248/jhs.52.711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/jhs.52.711</ArticleId></ArticleIdList></Reference><Reference><Citation>Horiuchi M., Wachi H., Seyama Y. Effects of Bidens pilosa L. var. Radiata Scherff on Experimental Gastric Lesion. J. Nat. Med. 2010;64:430&#x2013;435. doi: 10.1007/s11418-010-0426-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11418-010-0426-5</ArticleId><ArticleId IdType="pubmed">20526746</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosuge Y., Kaneko E., Nango H., Miyagishi H., Ishige K., Ito Y. Bidens pilosa Extract Administered after Symptom Onset Attenuates Glial Activation, Improves Motor Performance, and Prolongs Survival in a Mouse Model of Amyotrophic Lateral Sclerosis. Oxid. Med. Cell. Longev. 2020;2020:1020673. doi: 10.1155/2020/1020673.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/1020673</ArticleId><ArticleId IdType="pmc">PMC7008255</ArticleId><ArticleId IdType="pubmed">32089764</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai M.D., Yang E.J. Gamisoyo-San Ameliorates Neuroinflammation in the Spinal Cord of hSOD1G93A Transgenic Mice. Mediators Inflamm. 2018;2018:5897817. doi: 10.1155/2018/5897817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/5897817</ArticleId><ArticleId IdType="pmc">PMC6036813</ArticleId><ArticleId IdType="pubmed">30046279</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyagishi H., Kosuge Y., Ishige K., Ito Y. Expression of Microsomal Prostaglandin E Synthase-1 in the Spinal Cord in a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis. J. Pharmacol. Sci. 2012;118:225&#x2013;236. doi: 10.1254/jphs.11221FP.</Citation><ArticleIdList><ArticleId IdType="doi">10.1254/jphs.11221FP</ArticleId><ArticleId IdType="pubmed">22302024</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsen M.K., Roberds S.L., Ellerbrock B.R., Fleck T.J., McKinley D.K., Gurney M.E. Disease Mechanisms Revealed by Transcription Profiling in SOD1-G93A Transgenic Mouse Spinal Cord. Ann. Neurol. 2001;50:730&#x2013;740. doi: 10.1002/ana.1252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.1252</ArticleId><ArticleId IdType="pubmed">11761470</ArticleId></ArticleIdList></Reference><Reference><Citation>Tada S., Okuno T., Yasui T., Nakatsuji Y., Sugimoto T., Kikutani H., Sakoda S. Deleterious Effects of Lymphocytes at the Early Stage of Neurodegeneration in an Animal Model of Amyotrophic Lateral Sclerosis. J. Neuroinflamm. 2011;8:19. doi: 10.1186/1742-2094-8-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-8-19</ArticleId><ArticleId IdType="pmc">PMC3048550</ArticleId><ArticleId IdType="pubmed">21345177</ArticleId></ArticleIdList></Reference><Reference><Citation>Tada S., Okuno T., Hitoshi Y., Yasui T., Honorat J.A., Takata K., Koda T., Shimagami H., Chi-Jing C., Namba A., et al. Partial Suppression of M1 Microglia by Janus Kinase 2 Inhibitor Does Not Protect against Neurodegeneration in Animal Models of Amyotrophic Lateral Sclerosis. J. Neuroinflamm. 2014;11:179. doi: 10.1186/s12974-014-0179-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-014-0179-2</ArticleId><ArticleId IdType="pmc">PMC4213500</ArticleId><ArticleId IdType="pubmed">25326688</ArticleId></ArticleIdList></Reference><Reference><Citation>Cunha C., Santos C., Gomes C., Fernandes A., Correia A.M., Sebasti&#xe3;o A.M., Vaz A.R., Brites D. Downregulated Glia Interplay and Increased miRNA-155 as Promising Markers to Track ALS at an Early Stage. Mol. Neurobiol. 2018;55:4207&#x2013;4224. doi: 10.1007/s12035-017-0631-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0631-2</ArticleId><ArticleId IdType="pubmed">28612258</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu M., Wang J., Zhang X., Yan T., Wu B., Bi K., Jia Y. Polysaccharide from Schisandra Chinensis Acts via LRP-1 to Reverse Microglia Activation through Suppression of the NF-&#x3ba;B and MAPK Signaling. J. Ethnopharmacol. 2020;256:112798. doi: 10.1016/j.jep.2020.112798.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2020.112798</ArticleId><ArticleId IdType="pubmed">32251761</ArticleId></ArticleIdList></Reference><Reference><Citation>Valente G., Ozmen L., Novelli F., Geuna M., Palestro G., Forni G., Garotta G. Distribution of Interferon-&#x3b3; Receptor in Human Tissues. Eur. J. Immunol. 1992;22:2403&#x2013;2412. doi: 10.1002/eji.1830220933.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.1830220933</ArticleId><ArticleId IdType="pubmed">1387613</ArticleId></ArticleIdList></Reference><Reference><Citation>Khurana Hershey G.K. IL-13 Receptors and Signaling Pathways: An Evolving Web. J. Allergy Clin. Immunol. 2003;111:677&#x2013;690. doi: 10.1067/mai.2003.1333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mai.2003.1333</ArticleId><ArticleId IdType="pubmed">12704343</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong Z., Deane R., Ali Z., Parisi M., Shapovalov Y., O&#x2019;Banion M.K., Stojanovic K., Sagare A., Boillee S., Cleveland D.W., et al. ALS-Causing SOD1 Mutants Generate Vascular Changes Prior to Motor Neuron Degeneration. Nat. Neurosci. 2008;11:420&#x2013;422. doi: 10.1038/nn2073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn2073</ArticleId><ArticleId IdType="pmc">PMC2895310</ArticleId><ArticleId IdType="pubmed">18344992</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler E.A., Sengillo J.D., Sullivan J.S., Henkel J.S., Appel S.H., Zlokovic B.V. Blood&#x2013;Spinal Cord Barrier Breakdown and Pericyte Reductions in Amyotrophic Lateral Sclerosis. Acta Neuropathol. 2013;125:111. doi: 10.1007/s00401-012-1039-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1039-8</ArticleId><ArticleId IdType="pmc">PMC3535352</ArticleId><ArticleId IdType="pubmed">22941226</ArticleId></ArticleIdList></Reference><Reference><Citation>Epperly M.W., Fisher R., Rigatti L., Watkins S., Zhang X., Hou W., Shields D., Franicola D., Bayir H., Wang H., et al. Amelioration of Amyotrophic Lateral Sclerosis in SOD1G93A Mice by M2 Microglia from Transplanted Marrow. In Vivo. 2019;33:675&#x2013;688. doi: 10.21873/invivo.11526.</Citation><ArticleIdList><ArticleId IdType="doi">10.21873/invivo.11526</ArticleId><ArticleId IdType="pmc">PMC6559904</ArticleId><ArticleId IdType="pubmed">31028184</ArticleId></ArticleIdList></Reference><Reference><Citation>Noh M.Y., Cho K.A., Kim H., Kim S.M., Kim S.H. Erythropoietin Modulates the Immune-Inflammatory Response of a SOD1G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis (ALS) Neurosci. Lett. 2014;574:53&#x2013;58. doi: 10.1016/j.neulet.2014.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2014.05.001</ArticleId><ArticleId IdType="pubmed">24820540</ArticleId></ArticleIdList></Reference><Reference><Citation>Audet J.N., Gowing G., Paradis R., Soucy G., Julien J.P. Ablation of Proliferating Cells in the CNS Exacerbates Motor Neuron Disease Caused by Mutant Superoxide Dismutase. PLoS ONE. 2012;7:e34932. doi: 10.1371/journal.pone.0034932.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0034932</ArticleId><ArticleId IdType="pmc">PMC3327706</ArticleId><ArticleId IdType="pubmed">22523565</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiarotto G.B., Cartarozzi L.P., Perez M., Biscola N.P., Spejo A.B., Gubert F., Franc&#x105; Junior M., Mendez-Otero R., De Oliveira A.L.R. Tempol Improves Neuroinflammation and Delays Motor Dysfunction in a Mouse Model (SOD1G93A) of ALS. J. Neuroinflamm. 2019;16:218. doi: 10.1186/s12974-019-1598-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-019-1598-x</ArticleId><ArticleId IdType="pmc">PMC6857328</ArticleId><ArticleId IdType="pubmed">31727149</ArticleId></ArticleIdList></Reference><Reference><Citation>Koh S.H., Kim Y., Kim H.Y., Won Cho G., Kim K.S., Kim S.H. Recombinant Human Erythropoietin Suppresses Symptom Onset and Progression of G93A-SOD1 Mouse Model of ALS by Preventing Motor Neuron Death and Inflammation. Eur. J. Neurosci. 2007;25:1923&#x2013;1930. doi: 10.1111/j.1460-9568.2007.05471.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2007.05471.x</ArticleId><ArticleId IdType="pubmed">17439481</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Y.H., Guan P.P., Zhang S.Q., Guo Y.S., Wang P. Rofecoxib Attenuates the Pathogenesis of Amyotrophic Lateral Sclerosis by Alleviating Cyclooxygenase-2-Mediated Mechanisms. Front. Neurosci. 2020;14:817. doi: 10.3389/fnins.2020.00817.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00817</ArticleId><ArticleId IdType="pmc">PMC7438558</ArticleId><ArticleId IdType="pubmed">32903591</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrnes K.R., Stoica B.A., Fricke S., Di Giovanni S., Faden A.I. Cell Cycle Activation Contributes to Post-Mitotic Cell Death and Secondary Damage after Spinal Cord Injury. Brain. 2007;130:2977&#x2013;2992. doi: 10.1093/brain/awm179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awm179</ArticleId><ArticleId IdType="pubmed">17690131</ArticleId></ArticleIdList></Reference><Reference><Citation>Mi G., Gao Y., Liu S., Ye E., Li Y., Jin X., Yang H., Yang Z. Cyclin-Dependent Kinase Inhibitor Flavopiridol Promotes Remyelination in a Cuprizone Induced Demyelination Model. Cell Cycle. 2016;15:2780&#x2013;2791. doi: 10.1080/15384101.2016.1220458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15384101.2016.1220458</ArticleId><ArticleId IdType="pmc">PMC5053583</ArticleId><ArticleId IdType="pubmed">27580304</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.E., Park H., Choi S.H., Kong M.J., Kang T.C. Roscovitine Attenuates Microglia Activation and Monocyte Infiltration via P38 MAPK Inhibition in the Rat Frontoparietal Cortex Following Status Epilepticus. Cells. 2019;8:746. doi: 10.3390/cells8070746.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8070746</ArticleId><ArticleId IdType="pmc">PMC6678318</ArticleId><ArticleId IdType="pubmed">31331032</ArticleId></ArticleIdList></Reference><Reference><Citation>Akiko K., Yoshiyuki S., Eiji U., Takanori K., Makio S., Daisuke T., Genjiro K. Studies on the Antioxidant Active Constituents of the Dried Powder from Bidens pilosa L. var. radiata SCH. Nat. Med. 2003;57:100&#x2013;104.</Citation></Reference><Reference><Citation>Matsumoto T., Horiuchi M., Kamata K., Seyama Y. Effects of Bidens pilosa L. Var. radiata SCHERFF Treated with Enzyme on Histamine-Induced Contraction of Guinea Pig Ileum and on Histamine Release from Mast Cells. J. Smooth Muscle Res. 2009;45:75&#x2013;86. doi: 10.1540/jsmr.45.75.</Citation><ArticleIdList><ArticleId IdType="doi">10.1540/jsmr.45.75</ArticleId><ArticleId IdType="pubmed">19602852</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakatani Y., Yaguchi M., Ogino K., Noguchi R., Yamamoto N., Amano T. Duloxetine Ameliorates Lipopolysaccharide-Induced Microglial Activation by Suppressing INOS Expression in BV-2 Microglial Cells. Psychopharmacology. 2022;239:3133&#x2013;3143. doi: 10.1007/s00213-022-06194-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00213-022-06194-6</ArticleId><ArticleId IdType="pubmed">35882635</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosuge Y., Miyagishi H., Shinomiya T., Nishiyama K., Suzuki S., Osada N., Ishige K., Okubo M., Kawaguchi M., Ito Y. Characterization of Motor Neuron Prostaglandin E2 EP3 Receptor Isoform in a Mouse Model of Amyotrophic Lateral Sclerosis. Biol. Pharm. Bull. 2015;38:1964&#x2013;1968. doi: 10.1248/bpb.b15-00418.</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/bpb.b15-00418</ArticleId><ArticleId IdType="pubmed">26632188</ArticleId></ArticleIdList></Reference><Reference><Citation>Nango H., Kosuge Y., Miyagishi H., Sugawa K., Ito Y., Ishige K. Prostaglandin E2 Facilitates Neurite Outgrowth in a Motor Neuron-like Cell Line, NSC-34. J. Pharmacol. Sci. 2017;135:64&#x2013;71. doi: 10.1016/j.jphs.2017.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jphs.2017.09.001</ArticleId><ArticleId IdType="pubmed">28966102</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosuge Y., Nango H., Kasai H., Yanagi T., Mawatari T., Nishiyama K., Miyagishi H., Ishige K., Ito Y. Generation of Cellular Reactive Oxygen Species by Activation of the EP2 Receptor Contributes to Prostaglandin E2-Induced Cytotoxicity in Motor Neuron-Like NSC-34 Cells. Oxid. Med. Cell. Longev. 2020;2020:6101838. doi: 10.1155/2020/6101838.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/6101838</ArticleId><ArticleId IdType="pmc">PMC7201578</ArticleId><ArticleId IdType="pubmed">32411331</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>